Bisphenol A and bisphenol S induce distinct transcriptional profiles in differentiating human primary preadipocytes

PLoS ONE

Volumn 11, Issue 9, 2016, Pages

  Boucher, Jonathan G ^a   Gagné, Rémi ^a   Rowan Carroll, Andrea ^a   Boudreau, Adèle ^a   Yauk, Carole L ^a   Atlas, Ella ^a  

^a HEALTH CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; BISPHENOL S; CHOLESTEROL; DEXAMETHASONE; LIVER X RECEPTOR; PHENOL DERIVATIVE; POLYADENYLIC ACID; RETINOID X RECEPTOR; UNCLASSIFIED DRUG;

ADIPOGENESIS; ARTICLE; CELL DIFFERENTIATION; CHOLESTASIS; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LIPID METABOLISM; LIPOGENESIS; LIVER FIBROSIS; PROADIPOCYTE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; TRANSCRIPTION REGULATION;

EID: 84991829551     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0163318     Document Type: Article

References (54)

1. Rubin BS. Bisphenol A: an endocrine disruptor with widespread exposure and multiple effects. J Steroid Biochem Mol Biol. 2011; 127(1-2):27-34. doi: 10.1016/j.jsbmb.2011.05.002 PMID: 21605673.
2. Song H, Zhang T, Yang P, Li M, Yang Y, Wang Y, et al. Low doses of bisphenol A stimulate the proliferation of breast cancer cells via ERK1/2/ERRgamma signals. Toxicol In Vitro. 2015; 30(1 Pt B):521-8. doi: 10.1016/j.tiv.2015.09.009 PMID: 26363202.
3. Vom Saal FS, Nagel SC, Coe BL, Angle BM, Taylor JA. The estrogenic endocrine disrupting chemical bisphenol A (BPA) and obesity. Mol Cell Endocrinol. 2012; 354(1-2):74-84. doi: 10.1016/j.mce.2012.01.001 PMID: 22249005; PubMed Central PMCID: PMCPMC3306519.
4. Liao C, Kannan K. A survey of bisphenol A and other bisphenol analogues in foodstuffs from nine cities in China. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2014; 31(2):319-29. doi: 10.1080/19440049.2013.868611 PMID: 24262000.
5. Gallart-Ayala H, Moyano E, Galceran MT. Analysis of bisphenols in soft drinks by on-line solid phase extraction fast liquid chromatography-tandem mass spectrometry. Anal Chim Acta. 2011; 683(2):227-33. doi: 10.1016/j.aca.2010.10.034 PMID: 21167975.
6. Vinas P, Campillo N, Martinez-Castillo N, Hernandez-Cordoba M. Comparison of two derivatization-based methods for solid-phase microextraction-gas chromatography-mass spectrometric determination of bisphenol A, bisphenol S and biphenol migrated from food cans. Anal Bioanal Chem. 2010; 397(1):115-25. doi: 10.1007/s00216-010-3464-7 PMID: 20127078.
7. Liao C, Liu F, Moon HB, Yamashita N, Yun S, Kannan K. Bisphenol analogues in sediments from industrialized areas in the United States, Japan, and Korea: spatial and temporal distributions. Environ Sci Technol. 2012; 46(21):11558-65. doi: 10.1021/es303191g PMID: 23020513.
8. Liao C, Liu F, Alomirah H, Loi VD, Mohd MA, Moon HB, et al. Bisphenol S in urine from the United States and seven Asian countries: occurrence and human exposures. Environ Sci Technol. 2012; 46(12):6860-6. doi: 10.1021/es301334j PMID: 22620267.
9. Zhou X, Kramer JP, Calafat AM, Ye X. Automated on-line column-switching high performance liquid chromatography isotope dilution tandem mass spectrometry method for the quantification of bisphenol A, bisphenol F, bisphenol S, and 11 other phenols in urine. J Chromatogr B Analyt Technol Biomed Life Sci. 2014; 944:152-6. doi: 10.1016/j.jchromb.2013.11.009 PMID: 24316527.
10. Dairkee SH, Luciani-Torres MG, Moore DH, Goodson WH, 3rd. Bisphenol-A-induced inactivation of the p53 axis underlying deregulation of proliferation kinetics, and cell death in non-malignant human breast epithelial cells. Carcinogenesis. 2013; 34(3):703-12. doi: 10.1093/carcin/bgs379 PMID: 23222814; PubMed Central PMCID: PMCPMC3581603.
11. Lassen TH, Frederiksen H, Jensen TK, Petersen JH, Joensen UN, Main KM, et al. Urinary bisphenol A levels in young men: association with reproductive hormones and semen quality. Environ Health Perspect. 2014; 122(5):478-84. doi: 10.1289/ehp.1307309 PMID: 24786630; PubMed Central PMCID: PMCPMC4014766.
12. Melzer D, Rice NE, Lewis C, Henley WE, Galloway TS. Association of urinary bisphenol a concentration with heart disease: evidence from NHANES 2003/06. PLoS One. 2010; 5(1):e8673. doi: 10.1371/journal.pone.0008673 PMID: 20084273; PubMed Central PMCID: PMCPMC2800195.
13. Bhandari R, Xiao J, Shankar A. Urinary bisphenol A and obesity in U.S. children. Am J Epidemiol. 2013; 177(11):1263-70. doi: 10.1093/aje/kws391 PMID: 23558351; PubMed Central PMCID: PMCPMC3664337.
14. Eladak S, Grisin T, Moison D, Guerquin MJ, N'Tumba-Byn T, Pozzi-Gaudin S, et al. A new chapter in the bisphenol A story: bisphenol S and bisphenol F are not safe alternatives to this compound. Fertil Steril. 2015; 103(1):11-21. doi: 10.1016/j.fertnstert.2014.11.005 PMID: 25475787.
15. Rosenmai AK, Dybdahl M, Pedersen M, Alice van Vugt-Lussenburg BM, Wedebye EB, Taxvig C, et al. Are structural analogues to bisphenol a safe alternatives? Toxicol Sci. 2014; 139(1):35-47. doi: 10.1093/toxsci/kfu030 PMID: 24563381.
16. Goldinger DM, Demierre AL, Zoller O, Rupp H, Reinhard H, Magnin R, et al. Endocrine activity of alternatives to BPA found in thermal paper in Switzerland. Regul Toxicol Pharmacol. 2015; 71(3):453-62. doi: 10.1016/j.yrtph.2015.01.002 PMID: 25579646.
17. Atlas E, Pope L, Wade MG, Kawata A, Boudreau A, Boucher JG. Bisphenol A increases aP2 expression in 3T3L1 by enhancing the transcriptional activity of nuclear receptors at the promoter. Adipocyte. 2014; 3(3):170-9. doi: 10.4161/adip.28436 PMID: 25068083; PubMed Central PMCID: PMCPMC4110093.
18. Boucher JG, Boudreau A, Atlas E. Bisphenol A induces differentiation of human preadipocytes in the absence of glucocorticoid and is inhibited by an estrogen-receptor antagonist. Nutr Diabetes. 2014; 4: e102. doi: 10.1038/nutd.2013.43 PMID: 24418828; PubMed Central PMCID: PMCPMC3904083.
19. Boucher JG, Boudreau A, Ahmed S, Atlas E. In Vitro Effects of Bisphenol A beta-D-Glucuronide (BPA-G) on Adipogenesis in Human and Murine Preadipocytes. Environ Health Perspect. 2015; 123(12):1287-93. doi: 10.1289/ehp.1409143 PMID: 26018136; PubMed Central PMCID: PMCPMC4671229.
20. Masuno H, Kidani T, Sekiya K, Sakayama K, Shiosaka T, Yamamoto H, et al. Bisphenol A in combination with insulin can accelerate the conversion of 3T3-L1 fibroblasts to adipocytes. J Lipid Res. 2002; 43(5):676-84. PMID: 11971937.
21. Boucher JG, Ahmed S, Atlas E. Bisphenol S Induces Adipogenesis in Primary Human Preadipocytes From Female Donors. Endocrinology. 2016; 157(4):1397-407. doi: 10.1210/en.2015-1872 PMID: 27003841.
22. Helies-Toussaint C, Peyre L, Costanzo C, Chagnon MC, Rahmani R. Is bisphenol S a safe substitute for bisphenol A in terms of metabolic function? An in vitro study. Toxicol Appl Pharmacol. 2014; 280(2):224-35. doi: 10.1016/j.taap.2014.07.025 PMID: 25111128.
23. Ahmed S, Atlas E. Bisphenol S- and bisphenol A-induced adipogenesis of murine preadipocytes occurs through direct peroxisome proliferator-activated receptor gamma activation. Int J Obes (Lond). 2016. doi: 10.1038/ijo.2016.95 PMID: 27273607.
24. Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013; 29(1):15-21. doi: 10.1093/bioinformatics/bts635 PMID: 23104886; PubMed Central PMCID: PMCPMC3530905.
25. Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012; 9(4):357-9. doi: 10.1038/nmeth.1923 PMID: 22388286; PubMed Central PMCID: PMCPMC3322381.
26. Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010; 26(1):139-40. doi: 10.1093/bioinformatics/btp616 PMID: 19910308; PubMed Central PMCID: PMCPMC2796818.
27. Robinson MD, Oshlack A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 2010; 11(3):R25. doi: 10.1186/gb-2010-11-3-r25 PMID: 20196867; PubMed Central PMCID: PMCPMC2864565.
28. Tomlinson JJ, Boudreau A, Wu D, Atlas E, Hache RJ. Modulation of early human preadipocyte differentiation by glucocorticoids. Endocrinology. 2006; 147(11):5284-93. doi: 10.1210/en.2006-0267 PMID: 16873539.
29. Boucher JG, Husain M, Rowan-Carroll A, Williams A, Yauk CL, Atlas E. Identification of mechanisms of action of bisphenol a-induced human preadipocyte differentiation by transcriptional profiling. Obesity (Silver Spring). 2014; 22(11):2333-43. doi: 10.1002/oby.20848 PMID: 25047013.
30. Delfosse V, Grimaldi M, le Maire A, Bourguet W, Balaguer P. Nuclear receptor profiling of bisphenol-A and its halogenated analogues. Vitam Horm. 2014; 94:229-51. doi: 10.1016/B978-0-12-800095-3.00009-2 PMID: 24388193.
31. Ni Y, Ji C, Wang B, Qiu J, Wang J, Guo X. A Novel pro-adipogenesis factor abundant in adipose tissues and over-expressed in obesity acts upstream of PPARgamma and C/EBPalpha. J Bioenerg Biomembr. 2013; 45(3):219-28. doi: 10.1007/s10863-012-9492-6 PMID: 23239344.
32. Yin C, Xiao Y, Zhang W, Xu E, Liu W, Yi X, et al. DNA microarray analysis of genes differentially expressed in adipocyte differentiation. J Biosci. 2014; 39(3):415-23. doi: 10.1007/s12038-014-9412-5 PMID: 24845505.
33. Berger E, Heraud S, Mojallal A, Lequeux C, Weiss-Gayet M, Damour O, et al. Pathways commonly dysregulated in mouse and human obese adipose tissue: FAT/CD36 modulates differentiation and lipogenesis. Adipocyte. 2015; 4(3):161-80. doi: 10.4161/21623945.2014.987578 PMID: 26257990; PubMed Central PMCID: PMCPMC4496979.
34. Li F, Gu Y, Dong W, Li H, Zhang L, Li N, et al. Cell death-inducing DFF45-like effector, a lipid droplet-associated protein, might be involved in the differentiation of human adipocytes. FEBS J. 2010; 277(20):4173-83. doi: 10.1111/j.1742-4658.2010.07806.x PMID: 20945533.
35. Grahn TH, Zhang Y, Lee MJ, Sommer AG, Mostoslavsky G, Fried SK, et al. FSP27 and PLIN1 interaction promotes the formation of large lipid droplets in human adipocytes. Biochem Biophys Res Commun. 2013; 432(2):296-301. doi: 10.1016/j.bbrc.2013.01.113 PMID: 23399566; PubMed Central PMCID: PMCPMC3595328.
36. Xu Y, Gu Y, Liu G, Zhang F, Li J, Liu F, et al. Cidec promotes the differentiation of human adipocytes by degradation of AMPKalpha through ubiquitin-proteasome pathway. Biochim Biophys Acta. 2015; 1850(12):2552-62. doi: 10.1016/j.bbagen.2015.09.008 PMID: 26367078.
37. Li Y, Xu S, Mihaylova MM, Zheng B, Hou X, Jiang B, et al. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab. 2011; 13(4):376-88. doi: 10.1016/j.cmet.2011.03.009 PMID: 21459323; PubMed Central PMCID: PMCPMC3086578.
38. Ayala-Sumuano JT, Velez-Delvalle C, Beltran-Langarica A, Marsch-Moreno M, Cerbon-Solorzano J, Kuri-Harcuch W. Srebf1a is a key regulator of transcriptional control for adipogenesis. Sci Rep. 2011; 1:178. doi: 10.1038/srep00178 PMID: 22355693; PubMed Central PMCID: PMCPMC3240949.
39. Juge-Aubry CE, Somm E, Giusti V, Pernin A, Chicheportiche R, Verdumo C, et al. Adipose tissue is a major source of interleukin-1 receptor antagonist: upregulation in obesity and inflammation. Diabetes. 2003; 52(5):1104-10. doi: 10.2337/diabetes.52.5.1104 PMID: 12716739.
40. Sui Y, Ai N, Park SH, Rios-Pilier J, Perkins JT, Welsh WJ, et al. Bisphenol A and its analogues activate human pregnane X receptor. Environ Health Perspect. 2012; 120(3):399-405. doi: 10.1289/ehp.1104426 PMID: 22214767; PubMed Central PMCID: PMCPMC3295358.
41. Juvet LK, Andresen SM, Schuster GU, Dalen KT, Tobin KA, Hollung K, et al. On the role of liver X receptors in lipid accumulation in adipocytes. Mol Endocrinol. 2003; 17(2):172-82. doi: 10.1210/me.2001-0210 PMID: 12554745.
42. Hu X, Lazar MA. Transcriptional repression by nuclear hormone receptors. Trends Endocrinol Metab. 2000; 11(1):6-10. doi: 10.1016/s1043-2760(99)00215-5 PMID: 10652499.
43. Schwartz K, Lawn RM, Wade DP. ABC1 gene expression and ApoA-I-mediated cholesterol efflux are regulated by LXR. Biochem Biophys Res Commun. 2000; 274(3):794-802. doi: 10.1006/bbrc.2000.3243 PMID: 10924356.
44. Stukas S, May S, Wilkinson A, Chan J, Donkin J, Wellington CL. The LXR agonist GW3965 increases apoA-I protein levels in the central nervous system independent of ABCA1. Biochim Biophys Acta. 2012; 1821(3):536-46. doi: 10.1016/j.bbalip.2011.08.014 PMID: 21889608.
45. Cohen P, Miyazaki M, Socci ND, Hagge-Greenberg A, Liedtke W, Soukas AA, et al. Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science. 2002; 297(5579):240-3. doi: 10.1126/science.1071527 PMID: 12114623.
46. Beaven SW, Matveyenko A, Wroblewski K, Chao L, Wilpitz D, Hsu TW, et al. Reciprocal regulation of hepatic and adipose lipogenesis by liver X receptors in obesity and insulin resistance. Cell Metab. 2013; 18(1):106-17. doi: 10.1016/j.cmet.2013.04.021 PMID: 23823481; PubMed Central PMCID: PMCPMC4089509.
47. Wagner BL, Valledor AF, Shao G, Daige CL, Bischoff ED, Petrowski M, et al. Promoter-specific roles for liver X receptor/corepressor complexes in the regulation of ABCA1 and SREBP1 gene expression. Mol Cell Biol. 2003; 23(16):5780-9. doi: 10.1128/mcb.23.16.5780-5789.2003 PMID: 12897148; PubMed Central PMCID: PMCPMC166346.
48. Edwards PA, Tabor D, Kast HR, Venkateswaran A. Regulation of gene expression by SREBP and SCAP. Biochim Biophys Acta. 2000; 1529(1-3):103-13. doi: 10.1016/s1388-1981(00)00140-2 PMID: 11111080.
49. Brun RP, Tontonoz P, Forman BM, Ellis R, Chen J, Evans RM, et al. Differential activation of adipogenesis by multiple PPAR isoforms. Genes Dev. 1996; 10(8):974-84. doi: 10.1101/gad.10.8.974 PMID: 8608944.
50. Forman BM, Goode E, Chen J, Oro AE, Bradley DJ, Perlmann T, et al. Identification of a nuclear receptor that is activated by farnesol metabolites. Cell. 1995; 81(5):687-93. doi: 10.1016/0092-8674(95)90530-8 PMID: 7774010.
51. Kliewer SA, Moore JT, Wade L, Staudinger JL, Watson MA, Jones SA, et al. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell. 1998; 92(1):73-82. doi: 10.1016/s0092-8674(00)80900-9 PMID: 9489701.
52. Jiao Y, Lu Y, Li XY. Farnesoid X receptor: a master regulator of hepatic triglyceride and glucose homeostasis. Acta Pharmacol Sin. 2015; 36(1):44-50. doi: 10.1038/aps.2014.116 PMID: 25500875; PubMed Central PMCID: PMCPMC4571315.
53. Yang X, Downes M, Yu RT, Bookout AL, He W, Straume M, et al. Nuclear receptor expression links the circadian clock to metabolism. Cell. 2006; 126(4):801-10. doi: 10.1016/j.cell.2006.06.050 PMID: 16923398.
54. Li P, Fan W, Xu J, Lu M, Yamamoto H, Auwerx J, et al. Adipocyte NCoR knockout decreases PPAR-gamma phosphorylation and enhances PPARgamma activity and insulin sensitivity. Cell. 2011; 147(4):815-26. doi: 10.1016/j.cell.2011.09.050 PMID: 22078880; PubMed Central PMCID: PMCPMC3783197.